JPMorgan Reinstates Vertex (VRTX) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 553.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $553.15 | 52 Week High | $134.71 | |||
| Open | $553.15 | 52 Week Low | $73.31 | |||
| Day High | $553.15 | P/E | N/A | |||
| Day Low | $553.15 | EPS | $-1.98 | |||
| Volume | 372 | |||||
